TFDA-2024-0091-V491

Type II variation for application TFDA-2024-0091. Type II variation: Labeling Change for Infectivir — major revision

Variation Number
TFDA-2024-0091-V491
Type
Type II
Application
TFDA-2024-0091
Change
CHG-2022-0191
Status
Pending
Fee
€42,691
Submitted
2023-01-11
Approved
—
Description

Type II variation: Labeling Change for Infectivir — major revision